Cargando…
The risk of renal disease is increased in lambda myeloma with bone marrow amyloid deposits
BACKGROUND: Light chain amyloidosis (AL) is a rare deposition disease and is present in 10–15% of patients with myeloma (MM). In contrast to symptomatic AL in MM, presence of bone marrow (BM) amyloid deposits (AD) in MM is not connected to kidney damage. Renal AD but not BM-AD occur mostly in MM wit...
Autores principales: | Kozlowski, Piotr, Montgomery, Scott, Befekadu, Rahel, Hahn-Strömberg, Victoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345990/ https://www.ncbi.nlm.nih.gov/pubmed/28293126 http://dx.doi.org/10.2147/JBM.S129516 |
Ejemplares similares
-
Investigating the association between polymorphisms in connective tissue growth factor and susceptibility to colon carcinoma
por: AHMAD, ABRAR, et al.
Publicado: (2015) -
Extensive amyloid deposits in bone marrow aspirate smears
por: Li, Ting Hon Stanford, et al.
Publicado: (2020) -
Isolated bone marrow amyloid light chain amyloidosis coexisting with multiple myeloma
por: Álamo Moreno, José R., et al.
Publicado: (2023) -
Diffuse Normolipemic Plane Xanthomatosis with Immunoglobulin-Lambda Light-Chain Deposition in a Patient with Multiple Myeloma
por: Lee, Sul Hee, et al.
Publicado: (2019) -
High frequency of lambda gene activation in bone marrow pre-B cells
Publicado: (1984)